Skip to Content

What type of cancer is Rubraca used to treat?

Medically reviewed by Judith Stewart, BPharm. Last updated on Sep 30, 2020.

Official Answer

by Drugs.com

Rubraca (rucaparib) is used for the treatment of certain types of ovarian cancer and prostate cancer.

Rubraca belongs to the class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors which are targeted therapies used in the treatment of certain types of cancer.

Ovarian Cancer

Rubraca is used for the treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients who have a germline (inherited) and/or somatic (acquired) abnormal BRCA gene, and who have been treated with two or more types of chemotherapy.

Rubraca is also used for the maintenance treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has returned in patients who have received platinum-based chemotherapy.

See Inherited Risk: The BRCA Gene Explained

Prostate Cancer

Rubraca is used for the treatment of metastatic (has spread to other parts of the body) castration-resistant prostate cancer (prostate cancer that no longer responds to medical or surgical treatment that lowers testosterone) in patients that have a germline and/or somatic abnormal BRCA gene who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.

See Rubraca Prescribing Information

Related Medical Questions

Drug Information

Related Support Groups